Concepedia
Statistics
Publications
69
Citations
3.6K
H-Index
34
Active since
1992
Affiliations
The University of Sydney(Current)
Princess Alexandra Hospital
The University of Queensland
Royal Prince Alfred Hospital
Johnson & Johnson (Australia)
Laurent P. Rivory is an author at The University of Sydney specializing in pharmacology, medicine, and chemotherapy.
Publications per year
1992–2009
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase
Laurent P. Rivory, Mark R. Bowles, Jacques Robert et al. · Biochemical Pharmacology · 1996 · 231 citations
Medicine, Pharmacokinetics, Pharmacology +14
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
Laurent P. Rivory, Kellie A. Slaviero, Stephen Clarke · British Journal of Cancer · 2002 · 214 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +16
Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
Marie‐Christine Haaz, Laurent P. Rivory, C. Riché et al. · PubMed · 1998 · 159 citations
Medicine, Biochemistry, Pharmacology +17
Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype
Howard Gurney, Ma‐Li Wong, Rosemary L. Balleine et al. · Clinical Pharmacology & Therapeutics · 2007 · 142 citations
Veterinary Medicine, Pharmacokinetics, Pharmacology +15
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.
Laurent P. Rivory, Marie‐Christine Haaz, Pierre Canal et al. · PubMed · 1997 · 140 citations
Medicine, Pharmacokinetics, Pharmacology +15
1–5 of 69